Clinical Trials Directory

Trials / Completed

CompletedNCT05163340

Views of Nurses on Alarm Fatigue in ICUs

Nurses' Views on Alarm Fatigue and Its Reduction in Adult Intensive Care Units: Convergent Parallel Design

Status
Completed
Phase
Study type
Observational
Enrollment
67 (actual)
Sponsor
Akdeniz University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study focused on determining the views of nurses on alarm fatigue and its reduction in adult intensive care units.

Detailed description

Backround: Physiological monitoring of critically ill patients in ICU is a complex nursing task, and nurses are key professionals managing multiple monitoring devices. Aim: The aim of this study is to determine the views of nurses on alarm fatigue and its prevention in adult intensive care units. Study Design: In the study, the minimum sample size was calculated as 67 for a population size of 106 and a 95% confidence interval, taking into account the alarm fatigue standard deviation (σ=6.82) found in the Turkish validity study of the "Nurses' Alarm Fatigue Scale" (t=1.96; d=1) . Considering that there may be losses, 74 nurses will be included in the study by taking 10% more. In the qualitative phase of the research, intensive care nurses who agreed to be interviewed during the collection of quantitative data will be included. Method: In this study, parallel data type will be used in convergent parallel mixed design. The quantitative phase of the study is a descriptive study to determine alarm fatigue levels in nurses working in adult intensive care units. In the qualitative phase of the research; A case study will be conducted at the same time in order to examine the findings revealed with quantitative data in more depth and to determine the views of nurses on reducing alarm fatigue. Individual in-depth interviews will be held in a suitable room using the "Semi-Structured Interview Form" created by the researchers with those who agree to participate in the qualitative study.

Conditions

Timeline

Start date
2022-01-06
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2021-12-20
Last updated
2022-07-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05163340. Inclusion in this directory is not an endorsement.